Original Articles
19 May 2025
New papers
The effect of sauna on cardiac and skeletal muscle function in patients with HFpEF (SAUNA-HFpEF): rationale and design
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
32
Views
7
Downloads
Authors
Patients with heart failure with preserved ejection fraction (HFpEF) often experience dyspnea, fatigue, and exercise intolerance, which are closely linked to skeletal muscle dysfunction and structural abnormalities. The only proven intervention to enhance exercise capacity and quality of life in these patients is regular endurance exercise training. However, its long-term effectiveness is often limited due to poor patient adherence and mobility restrictions caused by sarcopenia, cachexia, or frailty. Therefore, novel therapeutic approaches targeting these unmet needs are urgently required. Sauna-HFpEF is an academic-led, mechanistic, prospective, single-arm, single-center pilot study designed to assess the safety, feasibility, and efficacy of intermittent hyperthermia (sauna therapy) in improving exercise capacity and quality of life in patients with heart failure with preserved ejection fraction (HFpEF), as well as to explore the underlying mechanisms. A total of 18 clinically stable outpatients with HFpEF were enrolled and participated in twice-weekly sauna sessions at 60°C over a 10-week period. Assessments were conducted at baseline and after the intervention, including: echocardiography, cardiopulmonary exercise testing, six-minute walk test, body composition analysis to assess skeletal muscle mass and fat tissue, isokinetic skeletal muscle strength measurement of the quadriceps, daily physical activity monitoring using wearable accelerometers for one week, blood biomarkers, including NT-proBNP, renal function, and inflammatory markers (GDF-15, IL-6), and quality-of-life questionnaires (SF-36, HADS, EQ-5D). Furthermore, to explore the underlying mechanisms of a potential sauna-induced effect, patients underwent two ultrasound-guided punch biopsies of the musculus vastus lateralis in the right quadriceps - one before and one after the intervention. The collected samples were analyzed for structural, metabolic, and mitochondrial changes to gain further insights into the physiological adaptations. Sauna-HFpEF is the first study to investigate the safety and efficacy of sauna therapy using a comprehensive bed-to-benchside approach within the same patient population. This study aimed to address the existing knowledge gap while providing a foundation for the design of a future randomized controlled trial.
Altmetrics
Downloads
Download data is not yet available.
Citations
1. Haykowsky MJ, Brubaker PH, John JM, et al. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol 2011;58:265-74. DOI: https://doi.org/10.1016/j.jacc.2011.02.055
2. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med.2006;355:260-9. DOI: https://doi.org/10.1056/NEJMoa051530
3. Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008;359:2456-67. DOI: https://doi.org/10.1056/NEJMoa0805450
4. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362:777-81. DOI: https://doi.org/10.1016/S0140-6736(03)14285-7
5. Bergstrom A, Andersson B, Edner M, et al. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur J Heart Fail 2004;6:453-61. DOI: https://doi.org/10.1016/j.ejheart.2004.02.003
6. Maeder MT, Thompson BR, Brunner-La Rocca HP, Kaye DM. Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol 2010;56:855-63. DOI: https://doi.org/10.1016/j.jacc.2010.04.040
7. Haykowsky MJ, Brubaker PH, Stewart KP, et al. Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. J Am Coll Cardiol 2012;60:120-8. DOI: https://doi.org/10.1016/j.jacc.2012.02.055
8. Bhella PS, Prasad A, Heinicke K, et al. Abnormal haemodynamic response to exercise in heart failure with preserved ejection fraction. Eur J Heart Fail 2011;13:1296-304. DOI: https://doi.org/10.1093/eurjhf/hfr133
9. Fulster S, Tacke M, Sandek A, et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J 2013;34:512-9. DOI: https://doi.org/10.1093/eurheartj/ehs381
10. Bekfani T, Pellicori P, Morris DA, et al. Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life. Int J Cardiol 2016;222:41-6. DOI: https://doi.org/10.1016/j.ijcard.2016.07.135
11. Stevenson LW, Sietsema K, Tillisch JH, et al. Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure. Circulation 1990;81:78-85. DOI: https://doi.org/10.1161/01.CIR.81.1.78
12. Maurer MS, Schulze PC. Exercise intolerance in heart failure with preserved ejection fraction: shifting focus from the heart to peripheral skeletal muscle. J Am Coll Cardiol 2012;60:129-31. DOI: https://doi.org/10.1016/j.jacc.2012.04.012
13. Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014;63:1123-33. DOI: https://doi.org/10.1016/j.jacc.2013.11.053
14. Cowie MR, Anker SD, Cleland JGF, et al. Improving care for patients with acute heart failure: before, during and after hospitalization. ESC Heart Fail 2014;1:110-45. DOI: https://doi.org/10.1002/ehf2.12021
15. Soundarraj D, Singh V, Satija V, Thakur RK. Containing the cost of heart failure management: a focus on reducing readmissions. Heart Fail Clin 2017;13:21-8. DOI: https://doi.org/10.1016/j.hfc.2016.07.002
16. Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation 2018;137:e67-e492. DOI: https://doi.org/10.1161/CIR.0000000000000573
17. van Oeffelen AA, Agyemang C, Stronks K, et al. Prognosis after a first hospitalisation for acute myocardial infarction and congestive heart failure by country of birth. Heart 2014;100:1436-43. DOI: https://doi.org/10.1136/heartjnl-2013-305444
18. Ryan AM, Nallamothu BK, Dimick JB. Medicare's public reporting initiative on hospital quality had modest or no impact on mortality from three key conditions. Health Aff (Millwood) 2012;31:585-92. DOI: https://doi.org/10.1377/hlthaff.2011.0719
19. van Riet EE, Hoes AW, Limburg A, et al. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur J Heart Fail 2014;16:772-7. DOI: https://doi.org/10.1002/ejhf.110
20. Stork S, Handrock R, Jacob J, et al. Epidemiology of heart failure in Germany: a retrospective database study. Clin Res Cardiol 2017;106:913-22. DOI: https://doi.org/10.1007/s00392-017-1137-7
21. Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 2018;391:572-80. DOI: https://doi.org/10.1016/S0140-6736(17)32520-5
22. Pan A. The real-world evidence of heart failure co-morbidities. Eur J Heart Fail 2017;19:434. DOI: https://doi.org/10.1002/ejhf.751
23. Bekfani T, Hamadanchi A, Ijuin S, et al. Relation of left atrial function with exercise capacity and muscle endurance in patients with heart failure. ESC Heart Fail 2021;8:4528-38. DOI: https://doi.org/10.1002/ehf2.13656
24. Bekfani T, Nisser J, Derlien S, et al. Psychosocial factors, mental health, and coordination capacity in patients with heart failure with preserved ejection fraction compared with heart failure with reduced ejection fraction. ESC Heart Fail 2021;8:3268-78. DOI: https://doi.org/10.1002/ehf2.13468
25. Bekfani T, Pellicori P, Morris D, et al. Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life. Clin Res Cardiol 2019;108:203-11. DOI: https://doi.org/10.1007/s00392-018-1344-x
26. Bekfani T, Schobel C, Pietrock C, et al. Heart failure and sleep-disordered breathing: susceptibility to reduced muscle strength and preclinical congestion (SICA-HF cohort). ESC Heart Fail 2020;7:2063-70. DOI: https://doi.org/10.1002/ehf2.12798
27. Peters AE, Pandey A, Ayers C, et al. Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT. ESC Heart Fail 2021;8:842-8. DOI: https://doi.org/10.1002/ehf2.13250
28. Bekfani T, Bekhite M, Neugebauer S, et al. Metabolomic profiling in patients with heart failure and exercise intolerance: kynurenine as a potential biomarker. Cells 2022;11:1674. DOI: https://doi.org/10.3390/cells11101674
29. Laukkanen T, Khan H, Zaccardi F, Laukkanen JA. Association between sauna bathing and fatal cardiovascular and all-cause mortality events. JAMA Intern Med 2015;175:542-8. DOI: https://doi.org/10.1001/jamainternmed.2014.8187
30. Hafen PS, Abbott K, Bowden J, et al. Daily heat treatment maintains mitochondrial function and attenuates atrophy in human skeletal muscle subjected to immobilization. J Appl Physiol (1985) 2019;127:47-57. DOI: https://doi.org/10.1152/japplphysiol.01098.2018
31. Kojima D, Nakamura T, Banno M, et al. Head-out immersion in hot water increases serum BDNF in healthy males. Int J Hyperthermia 2018;34:834-9. DOI: https://doi.org/10.1080/02656736.2017.1394502
32. Maniam J, Morris MJ. Voluntary exercise and palatable high-fat diet both improve behavioural profile and stress responses in male rats exposed to early life stress: role of hippocampus. Psychoneuroendocrinology 2010;35:1553-64. DOI: https://doi.org/10.1016/j.psyneuen.2010.05.012
33. Masuda A, Nakazato M, Kihara T, et al. Repeated thermal therapy diminishes appetite loss and subjective complaints in mildly depressed patients. Psychosom Med 2005;67:643-7. DOI: https://doi.org/10.1097/01.psy.0000171812.67767.8f
34. Kallstrom M, Soveri I, Oldgren J, et al. Effects of sauna bath on heart failure: A systematic review and meta-analysis. Clin Cardiol 2018;41:1491-501. DOI: https://doi.org/10.1002/clc.23077
35. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2021;42:3599-726. DOI: https://doi.org/10.1093/eurheartj/ehab368
36. von Haehling S, Assmus B, Bekfani T, et al. Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment. Clin Res Cardiol 2024;113:1287-305. DOI: https://doi.org/10.1007/s00392-024-02396-4
37. Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J 2012;33:2917-27. DOI: https://doi.org/10.1093/eurheartj/ehs221
38. Guazzi M, Arena R, Halle M, et al. 2016 Focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation 2016;133:e694-711. DOI: https://doi.org/10.1161/CIR.0000000000000406
39. Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes 2010;8:13. DOI: https://doi.org/10.1186/1477-7525-8-13
40. Djukanovic I, Carlsson J, Arestedt K. Is the hospital anxiety and depression scale (HADS) a valid measure in a general population 65-80 years old? A psychometric evaluation study. Health Qual Life Outcomes 2017;15:193. DOI: https://doi.org/10.1186/s12955-017-0759-9
41. McHorney CA, Ware JE Jr., Raczek AE. The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247-63. DOI: https://doi.org/10.1097/00005650-199303000-00006
42. Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA 1993;270:1702-7. DOI: https://doi.org/10.1001/jama.1993.03510140062030
43. Vetrovsky T, Siranec M, Frybova T, et al. Lifestyle walking intervention for patients with heart failure with reduced ejection fraction: The WATCHFUL trial. Circulation 2024;149:177-88. DOI: https://doi.org/10.1161/CIRCULATIONAHA.123.067395
44. Umehara T, Kaneguchi A, Kawakami W, et al.Association of muscle mass and quality with hand grip strength in elderly patients with heart failure. Heart Vessels 2022;37:1380-6. DOI: https://doi.org/10.1007/s00380-022-02046-7
45. Bekfani T, Bekhite Elsaied M, Derlien S, et al. Skeletal muscle function, structure, and metabolism in patients with heart failure with reduced ejection fraction and heart failure with preserved ejection fraction. Circ Heart Fail 2020;13:e007198. DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.120.007198
46. Forman DE, Daniels KM, Cahalin LP, et al. Analysis of skeletal muscle gene expression patterns and the impact of functional capacity in patients with systolic heart failure. J Card Fail 2014;20:422-30. DOI: https://doi.org/10.1016/j.cardfail.2014.03.007
47. Pandey A, Parashar A, Kumbhani D, et al. Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials. Circ Heart Fail 2015;8:33-40. DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.114.001615
48. Solomon SD, McMurray JJV, Vaduganathan M, et al. Finerenone in heart failure with mildly reduced or preserved ejection fraction. N Engl J Med 2024;391:1475-85. DOI: https://doi.org/10.1056/NEJMe2410904
49. Kosiborod MN, Abildstrøm SZ, Borlaug BA, et al. Semaglutide in Patients with heart failure with preserved ejection fraction and obesity. N Engl J Med 2023;389:1069-84. DOI: https://doi.org/10.1056/NEJMc2312296
50. Saitoh M, Ishida J, Doehner W, et al. Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016. Int J Cardio. 2017;238:5-11. DOI: https://doi.org/10.1016/j.ijcard.2017.03.155
51. Kukkonen-Harjula K, Oja P, Laustiola K, et al. Haemodynamic and hormonal responses to heat exposure in a Finnish sauna bath. Eur J Appl Physiol Occup Physiol 1989;58:543-50. DOI: https://doi.org/10.1007/BF02330710
52. Hannuksela ML, Ellahham S. Benefits and risks of sauna bathing. Am J Med 2001;110:118-26. DOI: https://doi.org/10.1016/S0002-9343(00)00671-9
53. Ohori T, Nozawa T, Ihori H, et al. Effect of repeated sauna treatment on exercise tolerance and endothelial function in patients with chronic heart failure. Am J Cardiol 2012;109:100-4. DOI: https://doi.org/10.1016/j.amjcard.2011.08.014
54. Kihara T, Biro S, Imamura M, et al. Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure. J Am Coll Cardiol 2002;39:754-9. DOI: https://doi.org/10.1016/S0735-1097(01)01824-1
55. Kihara T, Biro S, Ikeda Y, et al. Effects of repeated sauna treatment on ventricular arrhythmias in patients with chronic heart failure. Circ J 2004;68:1146-51. DOI: https://doi.org/10.1253/circj.68.1146
How to Cite
The effect of sauna on cardiac and skeletal muscle function in patients with HFpEF (SAUNA-HFpEF): rationale and design. (2025). Global Cardiology. https://doi.org/10.4081/cardio.2025.67
Copyright (c) 2025 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
